Development of Animal-free, Protein-Free and Chemically-Defined Media for NS0 Cell Culture

There has been a recent boom of monoclonal antibodies on the market, and a significant portion of them were produced by NS0 cell lines. As regulations become more stringent in ensuring production processes are free of potential contamination by adventitious agents, it is highly desirable to further develop serum-free media into ones that do not contain any components of animal origin, or ‘animal-free media’. Using a shake-flask batch culture system, recombinant proteins (human albumin and human insulin) and synthetic compounds (tropolone and ferric ammonium citrate) were identified to be capable of replacing the animal-sourced proteins commonly found in serum-free media for NS0 cell culture, namely bovine albumin, insulin and transferrin. The cholesterol requirement of NS0 cells was satisfied by the use of a commercially available non-proteinaceous, non-animal sourced cholesterol/fatty acid mix in place of bovine lipoproteins, which in effect also eliminated the need for recombinant albumin. In the animal-free medium thus formulated, NS0 cell lines, either the host or recombinant constructs, were all able to grow in batch culture to 1~ 3×106 viable cells/ml for multiple passages, with no requirement for gradual adaptation even when seeded from 10% serum-containing cultures. It was surprising to observe that the recombinant insulin was essentially ineffective as sodium salt compared to its zinc salt. Studies showed that the zinc deficiency in the former resulted in a rapid decline of cell viabilities. Supplementation of zinc ions greatly improved growth, and even led to the total replacement of recombinant insulin and hence the formulation of a protein-free medium. When the cell lines were adapted to cholesterol-independent growth which eliminated the need for any lipid source, a completely chemically-defined animal-free medium was formulated. In all cases, antibody production by various GS-NS0 constructs in animal-free media was stable for multiple passages and at least similar to the original serum-free medium containing the animal-sourced proteins. The medium also served well for cryopreservation of NS0 cells in the absence of serum.

[1]  C. Milstein,et al.  Preparation of monoclonal antibodies: strategies and procedures. , 1981, Methods in enzymology.

[2]  O. Ezaki.  IIb group metal ions (Zn2+, Cd2+, Hg2+) stimulate glucose transport activity by post-insulin receptor kinase mechanism in rat adipocytes. , 1989, The Journal of biological chemistry.

[3]  B. Buckland,et al.  Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production. , 1997, Biotechnology and bioengineering.

[4]  D. Jayme,et al.  An animal origin perspective of common constituents of serum-free medium formulations. , 1999, Developments in biological standardization.

[5]  M. Cabot,et al.  Effects of proximate cholesterol precursors and steroid hormones on mouse myeloma growth in serum-free medium , 1988, In Vitro Cellular & Developmental Biology.

[6]  O. Merten.  Safety issues of animal products used in serum-free media. , 1999, Developments in biological standardization.

[7]  S. Gorfien,et al.  Growth of NS0 Cells in Protein‐Free, Chemically Defined Medium , 2000, Biotechnology progress.

[8]  F. Franek,et al.  Iron compounds at high concentrations enable hybridoma growth in A protein-free medium , 1987, Biotechnology Letters.

[9]  Wei-Shou Hu,et al.  Analysis of the use of fortified medium in continuous culture of mammalian cells , 2004, Cytotechnology.

[10]  R. Field,et al.  Process development for the production of recombinant antibodies using the glutamine synthetase (GS) system , 2006, Cytotechnology.

[11]  T G Cotter,et al.  Cell death (apoptosis) in cell culture systems. , 1995, Trends in biotechnology.

[12]  C. Milstein,et al.  [1] Preparation of monoclonal antibodies: Strategies and procedures , 1981 .

[13]  M. Popp,et al.  A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Dickson,et al.  Advances in animal cell recombinant protein production: GS-NS0 expression system , 2000, Cytotechnology.

[15]  D. Jayme.  Nutrient optimization for high density biological production applications , 2004, Cytotechnology.

[16]  C. Milstein,et al.  Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusion , 1976, European journal of immunology.

[17]  Jayme Dw.  An animal origin perspective of common constituents of serum-free medium formulations. , 1999 .

[18]  E. Lai,et al.  Surface plasmon resonance-based immunoassays. , 2000, Methods.

[19]  D. Gurwitz,et al.  Inhibition of glycogen synthase kinase-3beta by bivalent zinc ions: insight into the insulin-mimetic action of zinc. , 2002, Biochemical and biophysical research communications.

[20]  D. Fong,et al.  Development and Optimization of Cell Culture Media Genomic and Proteomic Approaches , 2005 .

[21]  C. Vincent,et al.  Adventitious agents from animal-derived raw materials and production systems. , 1996, Developments in biological standardization.

[22]  M. Yap,et al.  Evaluation of insulin-mimetic trace metals as insulin replacements in mammalian cell cultures , 2004, Cytotechnology.

[23]  R. Field,et al.  Selecting and designing cell lines for improved physiological characteristics , 2004, Cytotechnology.

[24]  O. Merten.  Virus contaminations of cell cultures – A biotechnological view , 2002, Cytotechnology.

[25]  T. Okamoto,et al.  Cholesterol requirement of P3-X63-Ag8 and X63-Ag8.653 mouse myeloma cells for growth in vitro , 1987, The Journal of experimental medicine.

[26]  Liangzhi Xie,et al.  Applications of improved stoichiometric model in medium design and fed-batch cultivation of animal cells in bioreactor , 2004, Cytotechnology.

[27]  Alan T. Bull,et al.  Application of a statistical design to the optimization of culture medium for recombinant interferon-gamma production by Chinese hamster ovary cells , 1992, Applied Microbiology and Biotechnology.

[28]  D. Galbraith.  Transmissible spongiform encephalopathies and tissue cell culture , 2002, Cytotechnology.

[29]  R. Field,et al.  THE USE OF 2-HYDROXY-2,4,6-CYCLOHEPTARIN-l-ONE (TROPOLONE) AS A REPLACEMENT FOR TRANSFERRIN , 1994 .

[30]  M. J. Keen,et al.  The use of serum-free medium for the production of functionally active humanised monoclonal antibody from NS0 mouse myeloma cells engineered using glutamine synthetase as a selectable marker , 2004, Cytotechnology.

[31]  D. King,et al.  High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker , 1992, Bio/Technology.

[32]  K. Nilsson,et al.  Mammalian cell culture. , 1987, Methods in enzymology.

[33]  M. J. Keen,et al.  Adaptation of cholesterol-requiring NS0 mouse myeloma cells to high density growth in a fully defined protein-free and cholesterol-free culture medium , 1995, Cytotechnology.

[34]  L Xie,et al.  Integrated approaches to the design of media and feeding strategies for fed-batch cultures of animal cells. , 1997, Trends in biotechnology.

[35]  Ray Field,et al.  Improved Fermentation Processes for NS0 Cell Lines Expressing Human Antibodies and Glutamine Synthetase , 2003, Biotechnology progress.

[36]  O. Merten,et al.  A simple serum-free freezing medium for serum-free cultured cells. , 1995, Biologicals : journal of the International Association of Biological Standardization.